Source link : https://www.newshealth.biz/health-news/aspirin-fails-to-boost-survival-in-colorectal-cancer-trial/
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly improve disease-free survival (DFS) and overall survival, the phase III randomized ASCOLT study showed. Among 1,550 patients included in the modified intention-to-treat analysis, the 5-year DFS rate was 77% for those who received aspirin 200 mg daily for 3 […]
Author : News Health
Publish date : 2025-01-16 20:42:05
Copyright for syndicated content belongs to the linked Source.